Cargando…
Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations
STUDY QUESTION: Do women with BRCA1 or BRCA2 mutations have reduced ovarian reserve, as measured by circulating anti-Müllerian hormone (AMH) concentration? SUMMARY ANSWER: Women with a germline mutation in BRCA1 have reduced ovarian reserve as measured by AMH. WHAT IS KNOWN ALREADY: The DNA repair e...
Autores principales: | Phillips, Kelly-Anne, Collins, Ian M., Milne, Roger L., McLachlan, Sue Anne, Friedlander, Michael, Hickey, Martha, Stern, Catharyn, Hopper, John L., Fisher, Richard, Kannemeyer, Gordon, Picken, Sandra, Smith, Charmaine D., Kelsey, Thomas W., Anderson, Richard A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840025/ https://www.ncbi.nlm.nih.gov/pubmed/27094481 http://dx.doi.org/10.1093/humrep/dew044 |
Ejemplares similares
-
Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
por: McKinley, Joanne M, et al.
Publicado: (2007) -
Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer
por: Kiely, B. E., et al.
Publicado: (2011) -
Bilateral Salpingo-oophorectomy and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Assessing the Evidence
por: Conduit, Ciara, et al.
Publicado: (2021) -
Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
por: Phillips, KA, et al.
Publicado: (2012) -
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017)